Drug Trial Radar · NCT03831880
Patient Perception of Treatment Burden in Weekly Versus Daily Growth Hormone Injections in Children With GHD
Last checked: Nov 20, 2026Latest source record: Oct 14, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
87
Actual
Start
Feb 7, 2019
Primary completion
Aug 28, 2020
Study completion Aug 28, 2020
Sponsor
- Lead sponsor
- PfizerPfizer (PFE)
- Sponsor type
- Industry
- First posted
- Feb 6, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Crossover
- Masking
- None
- Primary purpose
- Other
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 3 years, up to 17 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is an open label randomized 24 week crossover trial assessing the treatment burden of a weekly growth hormone injection regimen (somatrogon) compared to a daily growth hormone injection regimen (Genotropin). Approximately 90 children with growth hormone deficiency who have been stable on treatment with daily Genotropin will be enrolled.
Conditions
- Growth Hormone Deficiency
Interventions
GenotropinDrug
Genotropin (dose \[mg\] at time of enrollment) given subcutaneously once daily
somatrogonDrug
0.66 mg/kg/week given subcutaneously once weekly
Primary outcomes
What the sponsor says the trial is designed to measure.
- Total Score Related to Overall Life Interference Assessed at Baseline, Using Dyad Clinical Outcomes Assessment 1 (DCOA 1) QuestionnaireTime frame: Baseline
- Total Score Related to Overall Life Interference Assessed at Week 12, Using DCOA 1 QuestionnaireTime frame: Week 12
- Total Score Related to Overall Life Interference Assessed at Week 24, Using DCOA 1 QuestionnaireTime frame: Week 24
- Total Score Related to Overall Life Interference by Treatment in Overall Study, Using DCOA 1 QuestionnaireTime frame: Baseline up to Week 24
Locations
32 sites in 5 countries. Site status is shown where the registry gives one.
Center of Excellence in Diabetes and Endocrinology
Sacramento, California
Children's Hospital Colorado
Aurora, Colorado
Rocky Mountain Pediatric Endocrinology
Centennial, Colorado
Pediatric Endocrine Associates, PC
Greenwood Village, Colorado
Nemours Children's Health System
Jacksonville, Florida
Nemours Children's Specialty Care
Jacksonville, Florida
Nemours Biomedical Research
Orlando, Florida
Nemours Children's Hospital
Orlando, Florida
Nemours Children's Clinic
Pensacola, Florida
Shriners Hospitals for Children
Tampa, Florida
Emory Children's Center
Atlanta, Georgia
IU Health Pharmacy
Indianapolis, Indiana
Riley Hospital for Children
Indianapolis, Indiana
Children's Mercy Hospital and Clinics
Kansas City, Missouri
Hackensack University Medical Center
Hackensack, New Jersey
Children's Hospital of Pittsburgh of UPMC
Pittsburgh, Pennsylvania
MultiCare Health System - Mary Bridge Children's Health Center
Tacoma, Washington
MultiCare Institute for Research & Innovation
Tacoma, Washington
First Pediatric Clinic UMHAT "St. Marina" EAD
Varna, Bulgaria
Fakultni nemocnice Brno, Pediatricka Klinika
Brno, Czechia
Nemocnicni lekarna FN Brno
Brno, Czechia
Fakultni nemocnice v Motole, Pediatricka klinika 2.LF UK a FN Motol
Prague, Czechia
Nemocnicni lekarna FN Motol
Prague, Czechia
Nemocnicna Lekaren Nudch
Bratislava, Slovakia
Národný ústav detských chorôb, Detská klinika
Bratislava, Slovakia
Detská fakultná nemocnica Košice Klinika detí a dorastu LF UPJŠ a DFN
Košice, Slovakia
Nemocnica lekaren DFN Kosice, Klinika deti a dorastu
Košice, Slovakia
St. Georges University Hospitals NHS Foundation Trust
London, United Kingdom
St. Georges University Hospital NHS Foundation Trust
London, United Kingdom
The Institute of Child Health, University College London
London, United Kingdom
Great Ormond Street Hospital
London, United Kingdom
NIHR Clinical Research Facility, Great Ormond Street Hospital for Children NHS Trust
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.